Ding YF - Search Results

1

Chemoprophylaxis, diagnosis, treatments, and discharge management of COVID-19: An evidence-based clinical practice guideline (updated version).

Jin YH, Zhan QY, Peng ZY, Ren XQ, Yin XT, Cai L, Yuan YF, Yue JR, Zhang XC, Yang QW, Ji J, Xia J, Li YR, Zhou FX, Gao YD, Yu Z, Xu F, Tu ML, Tan LM, Yang M, Chen F, Zhang XJ, Zeng M, Zhu Y, Liu XC, Yang J, Zhao DC, Ding YF, Hou N, Wang FB, Chen H, Zhang YG, Li W, Chen W, Shi YX, Yang XZ, Wang XJ, Zhong YJ, Zhao MJ, Li BH, Ma LL, Zi H, Wang N, Wang YY, Yu SF, Li LY, Huang Q, Weng H, Ren XY, Luo LS, Fan MR, Huang D, Xue HY, Yu LX, Gao JP, Deng T, Zeng XT, Li HJ, Cheng ZS, Yao X, Wang XH; Evidence-Based Medicine Chapter of China International Exchange and Promotive Association for Medical and Health Care (CPAM); Chinese Research Hospital Association (CRHA). Jin YH, et al. Among authors: ding yf. Mil Med Res. 2020 Sep 4;7(1):41. doi: 10.1186/s40779-020-00270-8. Mil Med Res. 2020. PMID: 32887670 Free PMC article.

2

Insulin-like Growth Factor 1 Mediates Adrenal Development Dysfunction in Offspring Rats Induced by Prenatal Food Restriction.

He Z, Lv F, Ding Y, Zhu C, Huang H, Zhang L, Guo Y, Wang H. He Z, et al. Arch Med Res. 2017 Aug;48(6):488-497. doi: 10.1016/j.arcmed.2017.11.013. Epub 2017 Dec 6. Arch Med Res. 2017. PMID: 29203053

3

Multiple beneficial outcomes of medication therapy management interventions in randomized control trials and non-randomized control trials: A protocol for systematic review and meta-analysis.

Deng ZJ, Ding YF, Peng SS, Wang L, Wei AH. Deng ZJ, et al. Among authors: ding yf. Medicine (Baltimore). 2022 Oct 28;101(43):e31491. doi: 10.1097/MD.0000000000031491. Medicine (Baltimore). 2022. PMID: 36316852 Free PMC article.

4

Clinical, economic and humanistic outcomes of medication therapy management services: A systematic review and meta-analysis.

Deng ZJ, Gui L, Chen J, Peng SS, Ding YF, Wei AH. Deng ZJ, et al. Among authors: ding yf. Front Pharmacol. 2023 Apr 5;14:1143444. doi: 10.3389/fphar.2023.1143444. eCollection 2023. Front Pharmacol. 2023. PMID: 37089963 Free PMC article.

5

Ethyl Acetate Extracts of Semen Impatientis Inhibit Proliferation and Induce Apoptosis of Human Prostate Cancer Cell Lines through AKT/ERK Pathways.

Wang T, Cai Y, Song W, Chen R, Hu D, Ye J, Liu L, Peng W, Zhang J, Wang S, Yang W, Liu J, Ding Y. Wang T, et al. Biomed Res Int. 2017;2017:1243515. doi: 10.1155/2017/1243515. Epub 2017 Mar 13. Biomed Res Int. 2017. PMID: 28386546 Free PMC article.

6

Simultaneous determination of dacomitinib and its major metabolite, O-desmethyl dacomitinib in human plasma by LC-MS/MS and its application to clinical testing in patients with non-small cell lung cancer.

Feng X, Ding Y, Zhang P, Fu Q, Zhang L, Zheng H. Feng X, et al. J Chromatogr B Analyt Technol Biomed Life Sci. 2021 Oct 1;1182:122940. doi: 10.1016/j.jchromb.2021.122940. Epub 2021 Sep 17. J Chromatogr B Analyt Technol Biomed Life Sci. 2021. PMID: 34564058

7

A real-world pharmacovigilance study of axitinib: data mining of the public version of FDA adverse event reporting system.

Shu Y, Ding Y, Dai B, Zhang Q. Shu Y, et al. Expert Opin Drug Saf. 2022 Apr;21(4):563-572. doi: 10.1080/14740338.2022.2016696. Epub 2021 Dec 31. Expert Opin Drug Saf. 2022. PMID: 34918584

8

Drug-Induced Hospital-Acquired Acute Kidney Injury in China: A Multicenter Cross-Sectional Survey.

Liu C, Yan S, Wang Y, Wang J, Fu X, Song H, Tong R, Dong M, Ge W, Wang J, Yang H, Wang C, Xia P, Zhao L, Shen S, Xie J, Xu Y, Ma P, Li H, Lu S, Ding Y, Jiang L, Lin Y, Wang M, Qiu F, Feng W, Yang L. Liu C, et al. Kidney Dis (Basel). 2021 Mar;7(2):143-155. doi: 10.1159/000510455. Epub 2020 Sep 30. Kidney Dis (Basel). 2021. PMID: 33824870 Free PMC article.

9

Cost-Effectiveness of Nivolumab Plus Chemotherapy vs. Chemotherapy as First-Line Treatment for Advanced Gastric Cancer/Gastroesophageal Junction Cancer/Esophagel Adenocarcinoma in China.

Shu Y, Ding Y, Zhang Q. Shu Y, et al. Front Oncol. 2022 Apr 20;12:851522. doi: 10.3389/fonc.2022.851522. eCollection 2022. Front Oncol. 2022. PMID: 35515123 Free PMC article.

10

Gastrointestinal adverse events associated with semaglutide: A pharmacovigilance study based on FDA adverse event reporting system.

Shu Y, He X, Wu P, Liu Y, Ding Y, Zhang Q. Shu Y, et al. Front Public Health. 2022 Oct 20;10:996179. doi: 10.3389/fpubh.2022.996179. eCollection 2022. Front Public Health. 2022. PMID: 36339230 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

216 results

Search Page

Filters